The largest database of trusted experimental protocols

Ni affinity column

Manufactured by GE Healthcare
Sourced in United Kingdom

The Ni affinity column is a laboratory equipment used for the purification of recombinant proteins containing a histidine tag. It utilizes the high-affinity interaction between nickel ions and the histidine residues to capture and separate the target protein from other components in a sample.

Automatically generated - may contain errors

5 protocols using ni affinity column

1

Purification of Ssa1 and Mutants

Check if the same lab product or an alternative is used in the 5 most similar protocols
Full-length Ssa1 (residues 2-642), truncated Ssa1 (residues 382-554) and corresponding mutations were purified as previously described (24) . Briefly, full-length Ssa1 and mutations were firstly purified on a Ni affinity column (GE Healthcare) in 50 mM Tris buffer (pH 7.5), 300 mM NaCl and 3 mM β-mercaptoethanol. Following Ulp1 cleavage to remove the N-terminal His-Smt3 tag and a second Ni affinity column purification, the flow through including tag-free protein was further purified by gel filtration chromatography (Superdex 200, GE Healthcare) in 50 mM Tris buffer (pH 7.5), 100 mM KCl and 5 mM MgCl2. The truncation mutants were similarly purified with some modifications to buffers.
For Ni affinity purification, 50 mM Tris buffer (pH 8.0) and 200 mM NaCl was used. Gel filtration chromatography was performed in 50 mM Na-phosphate buffer (pH 7.0) with 50 mM NaCl (Superdex 75, GE Healthcare).
+ Open protocol
+ Expand
2

Overexpression and Purification of TmoX1062

Check if the same lab product or an alternative is used in the 5 most similar protocols
The full-length tmoX1062 gene was amplified from the genomic DNA of HTCC1062 by PCR using FastPfu DNA polymerase (TransGen Biotech, China), and was subcloned into the NdeI/XhoI restriction sites of the pET22b (Novagen, America) vector with a C-terminal His-tag. All of the point mutations in tmoX1062 were performed with the QuikChange® mutagenesis kit II (Agilent, America). The wild-type (WT) TmoX1062 protein and all of the mutants were expressed in E. coli strain BL21(DE3). The recombinant E. coli strains were cultured at 37°C in LB medium to an OD600 of 0.8–1.0 and then incubated at 16°C for 16 h with 0.5 mM isopropyl β-D-1-thiogalactopyranoside (IPTG) as an inducer for recombinant protein expression. The recombinant proteins were purified first with Ni-affinity column (GE Healthcare, America), and then with gel filtration on a Superdex-75 column (GE Healthcare, America) eluted with the buffer containing 10 mM Tris–HCl (pH 8.0) and 100 mM NaCl. Approximately 2 mg recombinant TmoX1062 protein was obtained from 1 liter of culture.
+ Open protocol
+ Expand
3

Recombinant Protein Expression in E. coli

Check if the same lab product or an alternative is used in the 5 most similar protocols
The CAD coding region was amplified from Z58 and bm1-E plants and then sub-cloned into pET32a vector. The recombinant vectors were transferred into BL21 Escherichia coli cells. Cells were cultured at 37°C in Luria-Bertani medium. Isopropyl β-D-thiogalactopyranoside (IPTG) was added to a final concentration of 0.3 mM at mid-log phase (A600 = 0.4∼0.6). Cells were continued to be incubated at 18°C for 16 h and harvested by centrifugation at 5,000 × g for 5 min. Soluble proteins were extracted by sonication and the recombinant proteins were purified with Ni affinity column (GE Healthcare) for further enzyme activity (Youn et al., 2006 (link)).
+ Open protocol
+ Expand
4

Purification of Full-length and Truncated Ssa1

Check if the same lab product or an alternative is used in the 5 most similar protocols
Full-length Ssa1 (residues 2–642), truncated Ssa1 (residues 382–554) [51 ] and corresponding mutations were constructed in the pET28a-Smt3 vector containing 6× His and Smt3 tags [52 (link)]. The plasmid was transformed into BL21-CodonPlus (DE3)-RIL competent cells and induced by IPTG in 2YT medium. For NMR, M9 minimal medium containing 15N–NH4Cl or 15N–NH4Cl/13C–glucose was used. Full-length Ssa1 and mutations were first purified on an Ni affinity column (GE Healthcare) in 50 mM Tris buffer (pH 7.5), 300 mM NaCl, and 3 mM β-mercaptoethanol. Protein product was then incubated with Ulp1 followed by a second Ni affinity column purification step to remove the 6× His-Smt3 tag, Ulp1, and un-cleaved protein. The flow through was collected and further purified by gel filtration chromatography (Superdex 200, GE Healthcare) in 50 mM Tris buffer (pH 7.5), 100 mM KCl, and 5 mM MgCl2. The truncation mutants were similarly purified with some modifications to buffers. For Ni affinity purification, 50 mM Tris buffer (pH 8.0) and 200 mM NaCl were used. Gel filtration chromatography was performed in 50 mM Na–phosphate buffer (pH 7.0) with 50 mM NaCl (Superdex 75, GE Healthcare).
+ Open protocol
+ Expand
5

Purification and Interaction of SeASF1 and SeGtr1

Check if the same lab product or an alternative is used in the 5 most similar protocols
The Seasf1 was cloned into the pET28a vector after adding a 1×FLAG tag to the 5′-terminal of Seasf1 to make the Flag-SeASF1-His fusion protein. The Segtr1 was cloned into the pGEX-6P-1 vector to make the GST-SeGtr1 fusion protein (Table 2). Flag-SeASF1-His, GST-SeGtr1, pET28a or pGEX-6P-1 was expressed in BL21 strain of E. coli, and were then affinity purified with a Ni-affinity column (GE) or GST-affinity column (glutathione sepharoseTM 4B beads GE Healthcare, Little Chalfont, Buckinghamshire, UK). For glutathione S-transferase (GST) pull-down in vitro, GST-SeGtr1 and Flag-SeASF1-28a were expressed in E. coli strain BL21 (DE3). Total proteins of GST-SeGtr1 and Flag-SeASF1-His were then incubated with 4000 μL of glutathione sepharoseTM 4B beads at 4 °C for 2 h. The supernatant was removed, and the beads was washed by GST-lysis buffer three times. Finally, the beads were eluted by GST-elution buffer. Pull-down of GST-SeGtr1 with Flag-SeASF1-His was detected using an anti-Flag (Invitrogen, Waltham, MA, USA). Each experiment was repeated at least three times.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!